SCHEMBL25465740

SCHEMBL25465740

c1ccc(-c2cc3cc(-c4ccc(-c5c6ccccc6c(-c6ccccc6)c6ccccc56)cc4)ccc3o2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.57
PLA2G2A P14555 6/20 0.54
PLA2G4A P47712 6/20 0.54
CHRM2 P08172 1/20 0.49
CHRM4 P08173 1/20 0.49
CHRM5 P08912 1/20 0.49
CHRM1 P11229 1/20 0.49
CHRM3 P20309 1/20 0.49
PGR P06401 1/20 0.49
PLA2G10 O15496 1/20 0.48
ABCG2 Q9UNQ0 2/20 0.48
CYP1A1 P04798 1/20 0.48
CYP1A2 P05177 1/20 0.48
FYN P06241 1/20 0.48
MAPK3 P27361 1/20 0.48
AHR P35869 1/20 0.48
PAX8 Q06710 1/20 0.48
ESR1 P03372 1/20 0.47
ESR2 Q92731 1/20 0.47
FFAR1 O14842 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25056588 0.95 MAOB (0.55) MAOBPLA2G2APLA2G4ACHRM2CHRM4
SCHEMBL22954091 0.95 MAOB (0.58) MAOBPLA2G2APLA2G4ACHRM2CHRM4
SCHEMBL29598277 0.95 MAOB (0.58) MAOBPLA2G2APLA2G4ACHRM2CHRM4
SCHEMBL25465700 0.94 MAOB (0.57) MAOBPLA2G2APLA2G4ACHRM2CHRM4
SCHEMBL25056557 0.92 PLA2G2A (0.51) MAOBPLA2G2APLA2G4ACHRM2CHRM4
SCHEMBL3626409 0.90 MAOB (0.68) MAOBPLA2G2APLA2G4ACHRM2CHRM4
SCHEMBL25012942 0.90 MAOB (0.50) MAOBPLA2G2APLA2G4ACHRM2CHRM4
SCHEMBL25056566 0.89 MAOB (0.47) MAOBPLA2G2APLA2G4ACHRM2CHRM4
SCHEMBL25012323 0.87 MAOB (0.48) MAOBPLA2G2APLA2G4ACHRM2CHRM4
SCHEMBL25056549 0.87 MAOB (0.50) MAOBPLA2G2APLA2G4ACHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143961-A1 NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143961-A1 NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY2, TRPA1, ANXA1 MAOB 591/4885PLA2G2A 1457/4885PLA2G4A 1513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.